SEC Form 4 · accession 0001179110-17-011812
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy C. Peterson
Officer — CMO, Immuno-oncology
Period of report
Aug 22, 2017
Accepted (ET)
Aug 24, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Aug 22, 2017 | F | 28,185 | $5.3869 | D | 271,815 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to settle tax liability in connection with the vesting of a restricted share award that was previously granted on August 22, 2016. The share withholding was approved by a committee of non-employee directors in accordance with requirements of Rule 16b-3.
- F2Calculated based off the closing price of the Company's American Depositary Shares ("ADSs") on the date thereof. Each ADS represents 13 Ordinary Shares.